http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Tradewinds Universal Reinventing Nightlife Entertainment with a Scalable, Non-Dilutive Platform in $8-Billion Industry
-
nuEra Wraps Up Fifth Annual "Doobies for Boobies" Fundraiser Supporting Gilda's Club
-
Water Mission Brings Emergency Safe Water Equipment to Jamaica Ahead of Hurricane Melissa
-
ESGold Confirms Final Processing Methodology at Montauban as Construction Nears Completion
-
Members Trust of the Southwest Federal Credit Union Selects Mahalo Banking to Enhance Digital Experience Through Deep Core Integration
-
Ardelyx presents IBSRELA data at gastroenterology meeting
-
CyberDefenseCon 2025 Kicks Off with Top Global CISOs, Top InfoSec Innovators and Black Unicorn Awards for 2025
-
Ardelyx Presents Data that Continues to Support the Benefits of IBSRELA® (tenapanor) at the American College of Gastroenterology’s 2025 Annual Meeting
-
CREATE Medicines and Amsterdam University Medical Center Initiate First In Vivo CAR Therapy Trial in Frontline Setting for Solid Tumors
-
Three PKF O'Connor Davies Partners Recognized on Forbes' "America's Top 200 CPAs" List
-
Digital.ai’s 18th State of Agile Report Marks the Start of the Fourth Wave of Software Delivery: AI Is Transforming Agile from a Team Practice into an Enterprise-Wide Advantage
-
BeWhere Holdings Inc. Successfully Connects IoT Device on AST SpaceMobile's Direct-to-Device Satellite Network
-
Great Hill Partners Announces Strategic Growth Investment in Philanthropy Tech Platform Ren
-
MilliporeSigma Partners with Promega to Advance 3-D Cell Drug Discovery Technologies
-
nT-Tao Announces Jonathan Wurtele Joins Advisory Board to Strengthen Plasma & Accelerator Expertise
-
Tesla CEO Musk's partisan politics cost automaker over 1 million EV sales, report shows
-
TG Therapeutics completes enrollment for BRIUMVI dosing trial
-
BTQ Technologies Added to SamsungActive KoAct Global Quantum Computing Active ETF
-
Context Therapeutics to Participate in Upcoming Investor Conferences
-
Aurania Signs MOU with RSA S.R.L. and Firestone Ventures Inc. to Evaluate Potential Critical Metals Project in Europe
-
TG Therapeutics Completes Enrollment in the Phase 3 ENHANCE Trial Evaluating its New Simplified Dosing Schedule for BRIUMVI
-
Securitize to go public at $1.25 billion valuation via SPAC merger
-
Abitibi Metals appoints mining veteran Craig Parry to advisory board
-
Thermal Energy's First Quarter Highlighted by Record Q1 Order Intake and Higher Order Backlog
-
GENPREX collaborators present preclinical data for lung cancer therapy
-
Safe and Green Holdings Announces Its 2025 Record Date and Annual Shareholders Meeting Date
-
Securitize, the Leading Tokenization Platform, to Become a Public Company at $1.25B Valuation via Business Combination With Cantor Equity Partners II
-
Abitibi Metals Welcomes Mining Veteran and Shareholder Craig Parry to Its Advisory Board to Support the Next Phase of Growth
-
JCPenney Reminds America That This Holiday Season, It’s What They Thought That Counts
-
Date Change for Bike MS: Historic New Bern Ride 2026!
-
West Point Gold Drills 9.1m of 8.37 g/t Au within 82.4m of 1.61 g/t Au from Surface at the Tyro Main Zone
-
Genprex Collaborators Report Positive Preclinical Data on the Use of Reqorsa® Gene Therapy for the Treatment of Lung Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets an
-
Merck drug combination meets cancer trial endpoint in kidney cancer study
-
ESPAS and Steinehelden boost ecommerce productivity with Descartes system
-
Merck Announces KEYTRUDA® (pembrolizumab) Plus WELIREG® (belzutifan) Met Primary Endpoint of Disease-Free Survival (DFS) in Certain Patients With Clear Cell Renal Cell Carcinoma (RCC) Following Neph
-
ESPAS and Steinehelden Use Descartes’ Solution to Optimize Ecommerce Productivity by 500% While Supporting Special Needs of Workers
-
Silver Wolf Announces Life Offering of Units for up to CAD $1.5 Millon
-
WELIREG plus LENVIMA meets key endpoint in kidney cancer trial
-
Merck and Eisai Announce WELIREG® (belzutifan) Plus LENVIMA® (lenvatinib) Met Primary Endpoint of Progression-Free Survival (PFS) in Certain Previously Treated Patients With Advanced Renal Cell Carc
-
Hayasa Metals Announces Additional Drilling at Urasar Project
-
Check Point Software Reports 2025 Third Quarter Financial Results
-
Crypto Noah: How Noah Diermyer Built a Life of Freedom Through Focus, Faith, and Discipline
-
Ares Management and Slate buy Polish retail portfolio for over €300 million
-
Ares Management and Slate Asset Management to Acquire Polish Real Estate Portfolio Valued at Over €300 Million From Trei Real Estate
-
Experience the Future of Clean: CCE 2026 Invites Global Professionals to Shanghai
-
DMG Blockchain Solutions Announces Additional Partnership with Malahat Nation to Establish Indigenous-Led Regulated Utility for Clean Energy and AI Infrastructure
-
Novartis announces expiration of Tourmaline Bio tender offer
-
U.S. News Reveals 2026 Best Elementary and Middle Schools Rankings
-
BREAKING NEWS - Blazpay’s Crypto Presale Phase 2 Nears Completion
-
Greenberg Traurig's Ben McGuire Named 'Banking and Finance Attorney of the Year'
